In a lawsuit filed in a Los Angeles federal court, prominent players of the video game Call of Duty accused Microsoft Corp.'s (NASDAQ: MSFT) Activision Blizzard Inc.
In the near term, Lyra Therapeutics will focus on the two ongoing ENLIGHTEN Phase 3 trials evaluating LYR-210, a bioabsorbable sinonasal implant for the treatment of chronic rhinosinusitis (CRS). Lyra continues to